Leon J. Schurgers
VitaK
Maastricht University
Universiteitssingel 50
Maastricht
Netherlands
Name/email consistency: high
- Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Schurgers, L.J., Cranenburg, E.C., Vermeer, C. Thromb. Haemost. (2008)
- Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Schurgers, L.J., Spronk, H.M., Soute, B.A., Schiffers, P.M., DeMey, J.G., Vermeer, C. Blood (2007)
- Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. Schurgers, L.J., Spronk, H.M., Skepper, J.N., Hackeng, T.M., Shanahan, C.M., Vermeer, C., Weissberg, P.L., Proudfoot, D. J. Thromb. Haemost. (2007)
- Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Schurgers, L.J., Teunissen, K.J., Knapen, M.H., Kwaijtaal, M., van Diest, R., Appels, A., Reutelingsperger, C.P., Cleutjens, J.P., Vermeer, C. Arterioscler. Thromb. Vasc. Biol. (2005)
- Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Schurgers, L.J., Shearer, M.J., Hamulyák, K., Stöcklin, E., Vermeer, C. Blood (2004)
- Oral anticoagulant treatment: friend or foe in cardiovascular disease?. Schurgers, L.J., Aebert, H., Vermeer, C., Bültmann, B., Janzen, J. Blood (2004)